Impact on Survival of Early Versus Late Initiation of Adjuvant Chemotherapy After Pancreatic Adenocarcinoma Surgery: A Target Trial Emulation.
Jakob KirkegårdMorten LadekarlAndrea LundFrank MortensenPublished in: Annals of surgical oncology (2023)
Postponement of adjuvant chemotherapy up to 8 weeks after discharge from pancreatic adenocarcinoma surgery is safe and may allow more patients to receive adjuvant therapy due to better recovery.
Keyphrases
- minimally invasive
- coronary artery bypass
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- clinical trial
- prognostic factors
- surgical site infection
- peritoneal dialysis
- study protocol
- phase iii
- percutaneous coronary intervention
- atrial fibrillation
- acute coronary syndrome
- patient reported